4//SEC Filing
Khan Samina 4
Accession 0001209191-23-030192
CIK 0001358762other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:29 PM ET
Size
6.3 KB
Accession
0001209191-23-030192
Insider Transaction Report
Form 4
Khan Samina
SVP, Chief Medical Officer
Transactions
- Sale
Class A common stock
2023-05-15$85.32/sh−288$24,572→ 39,843 total - Sale
Class A common stock
2023-05-16$81.37/sh−352$28,642→ 39,491 total
Footnotes (1)
- [F1]The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001903865
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:29 PM ET
- Size
- 6.3 KB